SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000807249-24-000027
Filing Date
2024-02-27
Accepted
2024-02-27 16:02:26
Documents
1

Document Format Files

Seq Description Document Type Size
1 harp_00.htm SC 13D 272882
  Complete submission text file 0000807249-24-000027.txt   274729
Mailing Address 191 MASON STREET GREENWICH CT 06830
Business Address 191 MASON STREET GREENWICH CT 06830 9149215000
GAMCO INVESTORS, INC. ET AL (Filed by) CIK: 0000807249 (see all company filings)

IRS No.: 133056041 | State of Incorp.: DE | Fiscal Year End: 1031
Type: SC 13D
SIC: 0000

Mailing Address 611 GATEWAY BOULEVARD, SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 400 SOUTH SAN FRANCISCO CA 94080 (650) 443-7400
Harpoon Therapeutics, Inc. (Subject) CIK: 0001708493 (see all company filings)

IRS No.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90935 | Film No.: 24686364
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)